Panacea Index Logo

Command Palette

Search for a command to run...

Does the low FODMAP diet improve symptoms of radiation-induced enteropathy? A pilot study.

Scandinavian journal of gastroenterology
May 1, 2018
Trine Larsen et al. (6 authors)
Journal ArticleHuman Study
Study Details

Study Goal

The researchers aimed to investigate whether a Low-FODMAP Diet (LFD) could improve symptoms and health-related quality of life (HRQOL) in patients with radiation-induced enteropathy (RE).

Results Summary

The study found that LFD significantly improved IBS symptoms (based on IBS-SSS and IBS-SQ scores) and HRQOL (based on SF-NDI and SF-12 scores), though adherence was burdensome. Dietary changes included reduced intake of energy, carbohydrates, and fiber.

Population

11 female patients with radiation-induced enteropathy (RE) experiencing IBS-like symptoms.

Effective Dosage

Not specified (general dietary intervention).

Duration

4 weeks.

Interactions

None mentioned.

Extracted Claims (11)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
symptoms
patients with radiation-induced enteropathy (RE)
-
alleviate
#1
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
increase
health-related quality of life (HRQOL)
patients with radiation-induced enteropathy (RE)
-
improve
#2
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
FODMAP intake
patients with RE-related IBS symptoms
-
reduced
#3
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
IBS symptoms
patients with RE-related IBS symptoms
from 310.2 ± 60.7 to 171.4 ± 107.2
improved significantly
#4
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
IBS symptoms
patients with RE-related IBS symptoms
from 27.4 ± 4.1 to 15.7 ± 10.1
improved
#5
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
increase
HRQOL
patients with RE-related IBS symptoms
from 30.5 ± 9.4 to 18.3 ± 8.2
improved
#6
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
increase
mental score of SF-12
patients with RE-related IBS symptoms
-
improved
#7
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
increase
physical score of SF-12
patients with RE-related IBS symptoms
-
improved
#8
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
energy
patients with RE-related IBS symptoms
-
reduced intake
#9
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
carbohydrates
patients with RE-related IBS symptoms
-
reduced intake
#10
low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD)
decrease
fiber
patients with RE-related IBS symptoms
-
reduced intake
#11
Abstract

RATIONALE: Patients with radiation-induced enteropathy (RE) after cancer treatment show similar symptoms as patients with irritable bowel syndrome (IBS). The low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD) is a widespread management strategy for IBS. We aimed to investigate if there may be a positive effect of LFD on symptoms and health-related quality of life (HRQOL) in patients with RE. METHODS: In an open non-controlled pilot study, 11 patients (all female) with RE-related IBS symptoms were recruited largely based on own initiative. All followed LFD for four weeks. IBS Severity Scoring System (IBS-SSS) and IBS Symptom Questionnaire (IBS-SQ) were used to assess symptoms. Short Form Nepean Dyspepsia Index (SF-NDI) and 12-item Short Form Health Survey (SF-12) evaluated HRQOL. A three day food record was used to estimate baseline intake of FODMAPs and to reveal dietary changes. RESULTS: FODMAP intake was successfully reduced, although LFD was found a burdensome intervention. IBS symptoms improved significantly based on mean total score of IBS-SSS and IBS-SQ, which changed from 310.2 ± 60.7 to 171.4 ± 107.2 (p = .001) and 27.4 ± 4.1 to 15.7 ± 10.1 (p = .002). HRQOL improved based on SF-NDI total score (30.5 ± 9.4 to 18.3 ± 8.2, p = .001) and based on mental (p = .047) and physical (p = .134) score of SF-12. Main additional dietary changes were reduced intake of energy, carbohydrates, and fiber. CONCLUSION: Our findings from this small-scaled pilot study indicate that the LFD may alleviate symptoms and improve HRQOL in patients with RE. Further controlled studies with larger sample size should be conducted to verify our results and hopefully enable implementation of LFD as a future part of the management strategy for RE.

Medical Subject Headings (MeSH)
AdultDietDisaccharidesFemaleHumansIntestinal DiseasesIrritable Bowel SyndromeMaleMiddle AgedMonosaccharidesNeoplasmsNorwayOligosaccharidesPilot ProjectsQuality of LifeRadiation InjuriesSeverity of Illness Index
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality65/10
Citation Metrics
Total Citations7
Citations/Year1.0
Relative Citation Ratio0.29
NIH Percentile15.5%
Research Impact Scores
APT Score0.25
Weight Score1.74
Normalized Score0.67
Related Supplements